BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Woodsworth DJ, Dreolini L, Abraham L, Holt RA. Targeted Cell-to-Cell Delivery of Protein Payloads via the Granzyme-Perforin Pathway. Mol Ther Methods Clin Dev 2017;7:132-45. [PMID: 29201936 DOI: 10.1016/j.omtm.2017.10.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Liu Z, Yuan B, Zhao L, Huang L, Qin Y, Zhang J, Zhang J, Hu B, Yan Q. Function of the fliK Gene in Pseudomonas plecoglossicida Pathogenicity and Epinephelus coioides’ Immune Response. Front Mar Sci 2022;9:879333. [DOI: 10.3389/fmars.2022.879333] [Reference Citation Analysis]
2 Hu Q, Nonaka K, Wakiyama H, Miyashita Y, Fujimoto Y, Jogo T, Hokonohara K, Nakanishi R, Hisamatsu Y, Ando K, Kimura Y, Masuda T, Oki E, Mimori K, Oda Y, Mori M. Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer. Cancer Med 2021;10:3129-38. [PMID: 33769705 DOI: 10.1002/cam4.3828] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Roufas C, Georgakopoulos-Soares I, Zaravinos A. Molecular correlates of immune cytolytic subgroups in colorectal cancer by integrated genomics analysis. NAR Cancer 2021;3:zcab005. [PMID: 34316699 DOI: 10.1093/narcan/zcab005] [Reference Citation Analysis]
4 Fu X, Wang X, Duanmu J, Li T, Jiang Q. KRAS mutations are negatively correlated with immunity in colon cancer. Aging (Albany NY) 2020;13:750-68. [PMID: 33254149 DOI: 10.18632/aging.202182] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Zaravinos A, Roufas C, Nagara M, de Lucas Moreno B, Oblovatskaya M, Efstathiades C, Dimopoulos C, Ayiomamitis GD. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer. J Exp Clin Cancer Res 2019;38:364. [PMID: 31429779 DOI: 10.1186/s13046-019-1372-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
6 Azimi CS, Tang Q, Roybal KT, Bluestone JA. NextGen cell-based immunotherapies in cancer and other immune disorders. Current Opinion in Immunology 2019;59:79-87. [DOI: 10.1016/j.coi.2019.03.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
7 Vahedi F, Nassiri M, Ghovvati S, Javadmanesh A. Evaluation of Different Signal Peptides Using Bioinformatics Tools to Express Recombinant Erythropoietin in Mammalian Cells. Int J Pept Res Ther 2019;25:989-95. [DOI: 10.1007/s10989-018-9746-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
8 Narayanan S, Kawaguchi T, Yan L, Peng X, Qi Q, Takabe K. Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer. Ann Surg Oncol 2018;25:2323-31. [PMID: 29770915 DOI: 10.1245/s10434-018-6506-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 67] [Article Influence: 12.5] [Reference Citation Analysis]